These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3933399)

  • 1. Ultrastructural effects of alpha and gamma interferons and cytostatics on ovarian cancer cells in the subrenal capsule assay (SRCA).
    Söderström KO; Mäenpää J; Cantell K; Kangas L; Grönroos M
    Ann Chir Gynaecol Suppl; 1985; 199():38-43. PubMed ID: 3933399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA).
    Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M
    Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J; Kangas L; Grönroos M
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subrenal capsule assay in choosing cytostatics for gynaecological tumours.
    Mäenpää J; Grönroos M; Kangas L
    Ann Chir Gynaecol Suppl; 1985; 199():28-30. PubMed ID: 3864390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
    Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical praxis and laboratory procedures in subrenal capsule assay (SRCA).
    Kangas L; Perilä M
    Ann Chir Gynaecol Suppl; 1985; 199():7-11. PubMed ID: 3864393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology of transplanted tumours and drug induced regression in the subrenal capsule assay (SRCA) of mice and rats.
    Stenbäck F; Wasenius VM; Kangas L
    Ann Chir Gynaecol Suppl; 1985; 199():31-7. PubMed ID: 3904585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histological assessment of the four-day subrenal capsule assay (SRCA).
    Lévi F; Blum JP; Lemaigre G; Mechkouri M; Roulon A; Mathé G
    Ann Chir Gynaecol Suppl; 1985; 199():44-50. PubMed ID: 3864391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment.
    Aamdal S; Fodstad O; Pihl A
    Ann Chir Gynaecol Suppl; 1985; 199():51-9. PubMed ID: 3864392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subrenal capsule assay (SRCA) and its predictive value in oncology.
    Bogden AE
    Ann Chir Gynaecol Suppl; 1985; 199():12-27. PubMed ID: 3904584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II.
    Mäenpää J
    Obstet Gynecol; 1985 Nov; 66(5):714-8. PubMed ID: 3903584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
    Mäenpää JU; Heinonen E; Hinkka SM; Karnani P; Klemi PJ; Korpijaakko TA; Kuoppala TA; Laine AM; Lähde MA; Nuoranne EK
    Gynecol Oncol; 1995 Jun; 57(3):294-8. PubMed ID: 7774832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The subrenal capsule assay and gynecological cancer: five years of experience.
    Mäenpää J; Kangas L; Söderström KO; Grönroos M
    Ann Chir Gynaecol Suppl; 1987; 202():83-7. PubMed ID: 2444148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.
    Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP
    J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subrenal capsule assay for chemosensitivity testing].
    Kusuyama T; Fujita M; Shimozuma K; Orikasa H; Usugane M; Taguchi T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1143-9. PubMed ID: 3105468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique].
    Hirabayshi N; Nishiyama M; Yamaguchi M; Yoshinaka K; Nosoh Y; Toge T; Niimoto M; Hattori T; Ohkita T
    Gan To Kagaku Ryoho; 1985 May; 12(5):1056-62. PubMed ID: 3922307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 6-day subrenal capsule assay for predictive testing of primary esophageal cancers].
    Fukui H; Ide H; Hanyu F; Ikemoto H; Okushima N; Murata Y; Sato Y; Yamada A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1106-10. PubMed ID: 2436579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity test of anticancer agents by subrenal capsule assay (SRC assay). II--Determination of tumor sensitivity by percentage inhibition of DNA protein].
    Nishiyama M; Noso Y; Yamaguchi M; Hirabayashi N; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):275-9. PubMed ID: 3080963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
    Suonio E; Lipponen P; Mäenpää J; Syrjänen K; Kangas L; Tuomisto L
    Cancer Chemother Pharmacol; 1997; 41(1):15-21. PubMed ID: 9443609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice.
    Bennett JA; Pilon VA; MacDowell RT
    Cancer Res; 1985 Oct; 45(10):4963-9. PubMed ID: 4027980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.